Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-120105

Chief Scientific Officer sold 202,908 shares at an average $14.85 ($3,012,462)

From the SEC's structured data for this filing

Trades in this filing

Reich Kristian · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Sale : show line 1 in the form −130,000 $15.08 $1,960,400 72,908 D
2025-12-09 Sale : show line 2 in the form −72,908 $14.43 $1,052,062 0 D
Open-market sales · 202,908 sh · avg $14.85 · $3,012,462
Loading xslF345X05/ownership.xml…